Notably, Lip-1 and (S)-CRZ inhibited tumor growth to a similar extent whereas (R)-CRZ exhibited a stronger inhibitory effect on tumor growth, which supported the notion that (R)-CRZ may have dual roles in targeting RTKs in cancer cells and preventing ferroptosis in CD8+ T cells. Here, CD8A is linked to cancer.